Should a 78‑day‑old infant with a cough who has been receiving amoxicillin‑clavulanate for three days and has no fever discontinue the antibiotic and what is the appropriate management?

Management of 78-Day-Old Infant with Cough on Amoxicillin-Clavulanate

Stop the amoxicillin-clavulanate immediately—this infant does not meet criteria for bacterial infection requiring antibiotics. At 78 days old (approximately 11 weeks) with isolated cough and no fever, this presentation is most consistent with a viral upper respiratory infection that does not warrant antibiotic therapy.

Clinical Assessment Framework

Why Antibiotics Should Be Discontinued

In infants under 3 months with isolated cough and no fever, antibiotics are not indicated. The French guidelines explicitly state that acute bronchiolitis (the most common cause of cough in this age group) does not require first-line antibiotic therapy due to low risk of invasive bacterial infection 1. Antibiotics are only appropriate when specific bacterial infection criteria are met—none of which this infant demonstrates.

Specific Criteria That Would Justify Antibiotics (Currently Absent)

Amoxicillin-clavulanate would only be appropriate if this infant had:

• High fever ≥38.5°C persisting >3 days 1
• Associated purulent acute otitis media 1
• Radiographically confirmed pneumonia or atelectasis 1
• Severe respiratory distress with clinical pneumonia 2

None of these are present in this case.

The Harm-Benefit Analysis

Continuing unnecessary antibiotics exposes this infant to:

• Antibiotic-associated diarrhea (occurs in 5-44% of children on amoxicillin-clavulanate) 3
• Rash and dermatitis (approximately 5% additional risk) 3
• Disruption of intestinal microbiome with potential long-term consequences including increased risk of inflammatory bowel disease, obesity, eczema, and asthma 3
• Clostridium difficile infection risk 4
• Development of antimicrobial resistance 4

With no bacterial infection present, these harms far outweigh any theoretical benefit.

Appropriate Management Plan

Immediate Actions

1. Discontinue amoxicillin-clavulanate 4
2. Reassure parents that viral coughs in infants typically last 10-14 days and can persist up to 3-4 weeks
3. Provide supportive care instructions:
   • Maintain adequate hydration
   • Use nasal saline drops/suction for nasal congestion
   • Elevate head of crib slightly if tolerated
   • Avoid exposure to smoke and irritants

Red Flags Requiring Urgent Re-evaluation

Instruct parents to seek immediate medical attention if the infant develops:

• Fever ≥38.0°C (rectal temperature)
• Respiratory rate >70 breaths/minute 2
• Difficulty breathing, grunting, or chest indrawing 2
• Cyanosis or oxygen saturation <92% 2
• Apneic episodes 2
• Poor feeding or signs of dehydration 2
• Lethargy or decreased responsiveness

Follow-Up Timing

Re-evaluate within 48 hours if symptoms worsen or do not begin improving 2. Most viral respiratory infections show improvement by 3-5 days, though cough may persist longer.

Special Considerations for This Age Group

Why This Age Is Critical

At 78 days old, this infant falls into a transitional period:

• Too old for the extreme caution required in neonates <28 days
• Too young for the typical bacterial pathogens seen in older children (>3 months)
• Viral infections predominate in this age group, particularly RSV, rhinovirus, and other respiratory viruses

When to Reconsider Antibiotics

If clinical deterioration occurs with development of bacterial infection criteria, appropriate antibiotic choice would be:

For pneumonia (if radiographically confirmed):

• Amoxicillin 80-100 mg/kg/day divided three times daily (NOT amoxicillin-clavulanate unless specific indications) 1
• Duration: 5-10 days depending on clinical response 1, 5

For protracted bacterial bronchitis (if wet cough persists >4 weeks):

• Amoxicillin-clavulanate 22.5 mg/kg/dose twice daily for 2 weeks 6, 7
• Reassess at 2-3 days; therapeutic efficacy should be evident 1

Common Pitfalls to Avoid

1. Do not continue antibiotics "to complete the course" when they were inappropriately started—this outdated practice increases harm without benefit 4

2. Do not use cough suppressants or cold medications in infants—these are not FDA-approved for children <2 years and lack efficacy data 8

3. Do not assume all coughs require antibiotics—90% of lower respiratory tract infections in this age group are viral 1

4. Do not wait for "improvement" on inappropriate antibiotics—viral illnesses will improve regardless, creating false attribution of benefit

Evidence Quality Note

The recommendation to discontinue antibiotics is based on Grade C evidence from French national guidelines 1 and British Thoracic Society guidelines 2, which represent expert consensus supported by epidemiologic data showing viral etiology predominates in this clinical presentation. The harms of antibiotic use are supported by Grade A/B evidence from systematic reviews and RCTs 3.